Submissions from 2022
Shaping the Landscape of Brain Metastases Research: What Matters Most to Patients, Minesh Mehta
Providing Patients’ Tomorrow’s Care Today: Rapidly Bringing Discovery to the Bedside, Minesh Mehta
Coronary Atherosclerosis in an Asymptomatic US Population: Miami Heart Study at Baptist Health South Florida, Khurram Nasir, Shozab Ali, Lara Arias, Anshul Saxena, Theodore Feldman, Jack Ziffer, Jonathan Fialkow, and Ricardo Cury
Septic Arthritis in a Non-Prosthetic Joint Due to Mycobacterium Fortuitum: A Case Report, Solangel Rodriguez Materon and Thomas SanGiovanni
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy, Yazmin Odia, Doured Daghistani, Zuanel Diaz, and Matthew Hall
Clinical Trials Lessons Learned, Minesh Mehta
From Bench to Bedside to Beam: Radiotherapy Advances for Brain Tumors., Minesh Mehta
Effect of frailty on hospital outcomes among patients with cancer in the United States: Results from the National Inpatient Sample, Muni Rubens, Adrian Cristian, Venkataraghavan Ramamoorthy, Anshul Saxena, Peter McGranaghan, Raees Tonse, and Emir Veledar
Hospital Outcomes among COVID-19 Hospitalizations with Acute Ischemic Stroke: Cross-Sectional Study Results from California State Inpatient Database, Muni Rubens, Anshul Saxena, Venkataraghavan Ramamoorthy, Md Ashfaq Ahmed, Zhenwei Zhang, Peter McGranaghan, Emir Veledar, Michael McDermott, and Felipe De Los Rios La Rosa
The Graded Prognostic Assessment (GPA) for Lung Cancer Patients with Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA including the Effect of Programmed Death Ligand-1 (PD-L1) and Other Prognostic Factors, Tugce Kutuk, Rupesh Kotecha, Manmeet Ahluwalia, and Minesh Mehta
Multimodality Approaches to Primary and Secondary Brain Tumors, Minesh Mehta
Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: trial in progress, Rupesh Kotecha, Brian Schiro, Justin Sporrer, Muni Rubens, Haley Appel, Martin Tom, and Minesh Mehta
Pearls and Pitfalls in Conducting Neuro-Oncology Trials: Reflections of Experienced Clinical Trialists, Minesh Mehta
Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data, Tugce Kutuk, Haley Appel, Federico Albrecht, Paul Kaywin, Suyen Ramos, Minesh Mehta, and Rupesh Kotecha
Keynote B36: Open-label study of first-line tumor treating fields (150kHz) plus pembrolizumab for non-small cell lung cancer, Rupesh Kotecha
Multi-Institutional Patterns of Use and Compliance with Tumor Treating Fields for Patients with Unresectable Malignant Pleural Mesothelioma, Tugce Kutuk and Rupesh Kotecha
Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis, Federico Albrecht, Rupesh Kotecha, and Zhenwei Zhang
Intratumor and informatic heterogeneity influence meningioma molecular classification, Michael McDermott
Questioning the "Nickel Free" Total Knee Arthroplasty, Charles Lawrie
Management and outcomes of ST-segment elevation myocardial infarction in hospitalized frail patients in the United States, Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Juan Zevallos, and Sandra Chaparro